Clinical phenotypes of cystic fibrosis carriers
PM Polgreen, AP Comellas - Annual review of medicine, 2022 - annualreviews.org
Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in
CFTR, the cystic fibrosis transmembrane conductance regulator gene. People with CF …
CFTR, the cystic fibrosis transmembrane conductance regulator gene. People with CF …
[HTML][HTML] Personalized or precision medicine? The example of cystic fibrosis
FAL Marson, CS Bertuzzo, JD Ribeiro - Frontiers in pharmacology, 2017 - frontiersin.org
The advent of the knowledge on human genetics, by the identification of disease-associated
variants, culminated in the understanding of human variability. With the genetic knowledge …
variants, culminated in the understanding of human variability. With the genetic knowledge …
The chaperone UNC93B1 regulates Toll-like receptor stability independently of endosomal TLR transport
Summary Unc-93 homolog B1 (UNC93B1) is a key regulator of nucleic acid (NA)-sensing
Toll-like receptors (TLRs). Loss of NA-sensing TLR responses in UNC93B1-deficient …
Toll-like receptors (TLRs). Loss of NA-sensing TLR responses in UNC93B1-deficient …
Treatment of cystic fibrosis: from gene-to cell-based therapies
Prognosis of patients with cystic fibrosis (CF) varies extensively despite recent advances in
targeted therapies that improve CF transmembrane conductance regulator (CFTR) function …
targeted therapies that improve CF transmembrane conductance regulator (CFTR) function …
Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product*♦
PM Haggie, PW Phuan, JA Tan, H Xu… - Journal of Biological …, 2017 - ASBMB
W1282X is the fifth most common cystic fibrosis transmembrane regulator (CFTR) mutation
that causes cystic fibrosis. Here, we investigated the utility of a small molecule …
that causes cystic fibrosis. Here, we investigated the utility of a small molecule …
Genetics of cystic fibrosis
ME Egan - Clin. Chest Med, 2016 - books.google.com
Understanding the consequence of cystic fibrosis transmembrane conductance regulator
protein (CFTR) mutations is essential for prescribing appropriate drugs and providing …
protein (CFTR) mutations is essential for prescribing appropriate drugs and providing …
Cystic fibrosis diagnosis and newborn screening
M Rosenfeld, MK Sontag, CL Ren - Pediatric Clinics, 2016 - pediatric.theclinics.com
The landscape of the diagnosis of cystic fibrosis (CF) has changed dramatically over the
past decade, as universal screening for CF has become a reality in all 50 states in the …
past decade, as universal screening for CF has become a reality in all 50 states in the …
Cystic fibrosis: a model system for precision medicine
SL Martiniano, SD Sagel… - Current opinion in …, 2016 - journals.lww.com
CFTR modulators promise to transform the therapeutic landscape in CF in a precision based
fashion. Areas of ongoing research include developing drugs for all mutation classes so that …
fashion. Areas of ongoing research include developing drugs for all mutation classes so that …
[HTML][HTML] Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis
Cystic fibrosis (CF), a fatal genetic condition, causes thick, sticky mucus. It also causes
pancreatic dysfunction, bacterial infection, and increased salt loss. Currently available …
pancreatic dysfunction, bacterial infection, and increased salt loss. Currently available …
Cystic fibrosis and the nervous system
LR Reznikov - Chest, 2017 - Elsevier
Cystic fibrosis (CF) is a life-shortening autosomal recessive disorder caused by mutations in
the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR …
the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR …